Acute Reversible Cerebral Vasoconstriction Syndrome With Low-Dose Dihydroergotamine Possibly Potentiated by Valproic Acid and Erenumab: A Case Report
Journal of Neurology Research
doi 10.14740/jnr558
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2020
Authors
Publisher
Elmer Press, Inc.